Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor
- PMID: 11356952
- PMCID: PMC114257
- DOI: 10.1128/JVI.75.12.5457-5464.2001
Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor
Abstract
Human immunodeficiency virus type 1 (HIV-1) entry is triggered by the interaction of the gp120 envelope glycoprotein with a cellular chemokine receptor, either CCR5 or CXCR4. We have identified different mutations in human CXCR4 that prevent efficient infection by one HIV-1 strain (NDK) but not another (LAI) and sought to define these strain-dependent effects at the gp120 level. The lack of activity toward the NDK strain of the HHRH chimeric CXCR4 in which the second extracellular loop (ECL2) derived from the rat CXCR4 and of CXCR4 with mutations at an aspartic acid in ECL2 (D193A and D193R) was apparently due to the sequence of the third variable loop (V3) of gp120, more precisely, to its C-terminal part. Indeed, substitution of the LAI V3 loop or only its C-terminal part in the NDK gp 120 context was sufficient to restore usage of the HHRH, D193A, and D193R receptors. The same result was achieved upon mutation of a single lysine residue of the NDK V3 loop to alanine (K319A) but not to arginine (K319R). These results provide a strong case for a direct interaction between the gp120 V3 loop and the ECL2 domain of CXCR4. By contrast, V3 substitutions had no effect on the inability of NDK to infect cells via a mutant CXCR4 in which the amino-terminal extracellular domain (NT) is deleted. In experiments with a set of chimeric NDK-LAI gp120s, the V1/V2 region from LAI gp120 was both necessary and sufficient for usage of the NT-deleted CXCR4. Different variable domains of gp120 can therefore cooperate for a functional interaction with CXCR4.
Figures






Similar articles
-
Interactions among HIV gp120, CD4, and CXCR4: dependence on CD4 expression level, gp120 viral origin, conservation of the gp120 COOH- and NH2-termini and V1/V2 and V3 loops, and sensitivity to neutralizing antibodies.Virology. 1998 Sep 1;248(2):394-405. doi: 10.1006/viro.1998.9282. Virology. 1998. PMID: 9721247
-
N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism.J Virol. 2001 Jul;75(13):5998-6006. doi: 10.1128/JVI.75.13.5998-6006.2001. J Virol. 2001. PMID: 11390601 Free PMC article.
-
The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.Virology. 1998 Nov 10;251(1):59-70. doi: 10.1006/viro.1998.9392. Virology. 1998. PMID: 9813203
-
Synthetic peptides for study of human immunodeficiency virus infection.Appl Biochem Biotechnol. 2002 Jul-Dec;102-103(1-6):41-7. doi: 10.1385/abab:102-103:1-6:041. Appl Biochem Biotechnol. 2002. PMID: 12396109 Review.
-
HIV entry inhibitors: mechanisms of action and resistance pathways.J Antimicrob Chemother. 2006 Apr;57(4):619-27. doi: 10.1093/jac/dkl027. Epub 2006 Feb 7. J Antimicrob Chemother. 2006. PMID: 16464888 Review.
Cited by
-
A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12.J Virol. 2003 Jun;77(12):6965-78. doi: 10.1128/jvi.77.12.6965-6978.2003. J Virol. 2003. PMID: 12768015 Free PMC article.
-
Structure-guided design and immunological characterization of immunogens presenting the HIV-1 gp120 V3 loop on a CTB scaffold.Virology. 2010 Sep 30;405(2):513-23. doi: 10.1016/j.virol.2010.06.027. Epub 2010 Jul 21. Virology. 2010. PMID: 20663531 Free PMC article.
-
Baseline resistance of primary human immunodeficiency virus type 1 strains to the CXCR4 inhibitor AMD3100.J Virol. 2008 Dec;82(23):11695-704. doi: 10.1128/JVI.01303-08. Epub 2008 Sep 17. J Virol. 2008. PMID: 18799588 Free PMC article.
-
High affinity CXCR4 inhibitors generated by linking low affinity peptides.Eur J Med Chem. 2019 Jun 15;172:174-185. doi: 10.1016/j.ejmech.2019.03.056. Epub 2019 Apr 1. Eur J Med Chem. 2019. PMID: 30978562 Free PMC article.
-
Effect of Amino Acid Substitutions Within the V3 Region of HIV-1 CRF01_AE on Interaction with CCR5-Coreceptor.AIDS Res Hum Retroviruses. 2017 Sep;33(9):946-951. doi: 10.1089/AID.2017.0044. Epub 2017 Jun 12. AIDS Res Hum Retroviruses. 2017. PMID: 28497977 Free PMC article.
References
-
- Berger E A, Murphy P M, Farber J M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol. 1999;17:657–700. - PubMed
-
- Berson J F, Doms R W. Structure-function studies of the HIV-1 coreceptors. Semin Immunol. 1998;10:237–248. - PubMed
-
- Bleul C C, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer T A. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature. 1996;382:829–833. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials